Larotrectinib Capsules and Mycophenolate Suspension
Determining the interaction of Larotrectinib Capsules and Mycophenolate Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: mycophenolate mofetil
Brand name: Cellcept, Myfortic, MMF
Synonyms: Mycophenolate mofetil (oral/injection), Mycophenolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Mycophenolate Tablets
- Larotrectinib Capsules-Mycophenolate Tablets Delayed Release
- Larotrectinib Capsules-Mycophenolic acid
- Larotrectinib Capsules-Mycophenolic Acid Delayed-Release Tablets
- Larotrectinib Capsules-Mycophenolic Acid Tablets
- Larotrectinib Capsules-Mycostatin (Nystatin Oral Suspension)
- Mycophenolate Suspension-Larotrectinib Oral Solution
- Mycophenolate Suspension-Larotrectinib Sulfate
- Mycophenolate Suspension-Lartruvo
- Mycophenolate Suspension-Larynex
- Mycophenolate Suspension-Laryng-O-Jet
- Mycophenolate Suspension-Laryngesic